Diabetes – already prevalent worldwide, its incidence is expected to continue to grow exponentially in the coming years. This disease in which the body fails to produce or respond appropriately to the insulin hormone manifests in two types: type 1 and type 2, and if untreated, results in dangerously elevated glucose levels in the blood and urine. Prolonged hyperglycemia (high blood sugar) can lead to serious complications, including cardiovascular disease, kidney failure, diabetic retinopathy or nephropathy, and ulcers.
Follow the latest developments in diabetes with detailed market reports, forecasts, analysis, and more.
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.